PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Biologists develop new method for discovering antibiotics

2013-09-17
Biologists at the University of California, San Diego have developed a revolutionary new method for identifying and characterizing antibiotics, an advance that could lead to the discovery of new antibiotics to treat antibiotic resistant bacteria. The researchers, who published their findings in this week's early online edition of the journal Proceedings of the National Academy of Sciences, made their discovery by developing a way to perform the equivalent of an autopsy on bacterial cells. "This will provide a powerful new tool for identifying compounds that kill bacteria ...

SF State researchers steer light in new directions

2013-09-17
SAN FRANCISCO, Sept. 16, 2013 -- A team of researchers led by San Francisco State University's Weining Man is the first to build and demonstrate the ability of two-dimensional disordered photonic band gap material, designed to be a platform to control light in unprecedented ways. The new material could allow researchers to manipulate the flow and radiation of light in new ways by breaking away from the highly angular and constrained pathways for light dictated inside orderly photonic crystals. Instead, the material could lead to arbitrarily shaped, wavy, curved, and sharply ...

Whole DNA sequencing reveals mutations, new gene for blinding disease

2013-09-17
BOSTON -- Retinitis pigmentosa (RP) is a genetic disease that causes progressive loss of vision and is caused by mutations in more than 50 genes. Conventional methods for identification of both RP mutations and novel RP genes involve the screening of DNA coding sequences. In a paper in the Proceedings of the National Academy of Sciences, researchers from the Massachusetts Eye and Ear, Harvard Medical School, the University of Lausanne, Switzerland, and others tested DNA with the use of whole genome sequencing, a technique that takes into account all variants from both ...

Vaccinating cattle against E. coli O157 could cut human cases of infection by 85 percent, say scientists

2013-09-17
Vaccinating cattle against the E. coli O157 bacterium could cut the number of human cases of the disease by 85%, according to scientists. The bacteria, which cause severe gastrointestinal illness and even death in humans, are spread by consuming contaminated food and water, or by contact with livestock faeces in the environment. Cattle are the main reservoir for the bacterium. The vaccines that are available for cattle are rarely used, buc could be significant. The research was lead by a team of researchers at the University of Glasgow in collaboration with the ...

Copper bracelets and magnetic wrist straps fail to help rheumatoid arthritis, says York research

2013-09-17
Copper bracelets and magnet wrist straps have no real effect on pain, swelling, or disease progression in rheumatoid arthritis, according to new findings from a study conducted at the University of York. In the first randomised controlled trial to study the effects of copper bracelets and magnetic wrist straps on rheumatoid arthritis, 70 patients with active symptoms each wore four different devices over a five-month period, reporting on their pain, disability, and medication use throughout the study. Participants also provided blood samples, after wearing each device ...

Young breast cancer patients often overestimate benefit of having healthy breast removed

2013-09-17
BOSTON -- Young women with breast cancer often overestimate the odds that cancer will occur in their other, healthy breast, and decide to have the healthy breast surgically removed, a survey conducted by Dana-Farber Cancer Institute investigators indicates. The survey also shows that many patients opt for the procedure -- known as a contralateral prophylactic mastectomy, or CPM -- despite knowing it will be unlikely to improve their chance of survival. The study, published in the Sept. 17 issue of the Annals of Internal Medicine, shows a certain disconnect between ...

Sanford-Burnham researchers identify new target for melanoma treatment

2013-09-17
LA JOLLA, Calif., September 16, 2013 – Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) today announced the discovery that a gene encoding an enzyme, phosphoinositide-dependent kinase-1 (PDK1), plays an essential role in the development and progression of melanoma. The finding offers a new approach to treating this life-threatening disease. The team of researchers, led by Ze'ev Ronai, Ph.D., professor and scientific director of Sanford-Burnham Medical Research Institute in La Jolla (San Diego, Calif.), used genetic mouse melanoma models to show ...

Researchers identify novel biomarker for diabetes risk

2013-09-17
Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease. Thomas J. Wang, M.D., director of the Division of Cardiology at Vanderbilt, along with colleagues at Massachusetts General Hospital, report their findings in the October issue of The Journal of Clinical Investigation. The researchers conducted a study of 188 individuals who developed type 2 diabetes mellitus and 188 individuals without diabetes who were followed for 12 years ...

NASA to investigate Tropical Storm Humberto: Atlantic's second 'zombie tropical storm'

2013-09-17
Humberto is the second "zombie" tropical storm of the Atlantic Ocean season. That is, it's the second tropical storm that degenerated into a remnant low pressure area only to make a comeback as a tropical storm. NASA's HS3 hurricane mission sent an unmanned Global Hawk Aircraft out to the eastern Atlantic to investigate Humberto on Sept. 16. On Sunday, Sept. 15, Humberto weakened to a remnant low pressure area when it hit an area of strong wind shear. The wind shear eased and Humberto regained tropical storm strength on Sept. 16, making it the second "zombie" storm in ...

Wide-faced men make others act selfishly

2013-09-17
RIVERSIDE, Calif. — Two assistant professors of management at the University of California, Riverside and several other researchers have previously shown that men with wider faces are more aggressive, less trustworthy and more prone to engaging in deception. Now, in a just-published paper, they have shown, in a series of four studies, that individuals behave more selfishly when interacting with men with wider faces and this selfish behavior elicits selfish behavior in others. "This clearly shows that this behavior is also socially driven, not just biologically driven," ...

It's a shock: Life on Earth may have come from out of this world

2013-09-17
A group of international scientists including a Lawrence Livermore National Laboratory researcher have confirmed that life really could have come from out of this world. The team shock compressed an icy mixture, similar to what is found in comets, which then created a number of amino acids – the building blocks of life. The research appears in advanced online publication Sept. 15 on the Nature Geosciences journal website. This is the first experimental confirmation of what LLNL scientist Nir Goldman first predicted in 2010 and again in 2013 using computer simulations ...

TV drug ads: The whole truth?

2013-09-17
LEBANON, NH (Sept. 16, 2013) – Consumers should be wary when watching those advertisements for pharmaceuticals on the nightly TV news, as six out of 10 claims could potentially mislead the viewer, say researchers in an article published in the Journal of General Internal Medicine. Researchers Adrienne E. Faerber of The Dartmouth Institute for Health Policy & Clinical Practice and David H. Kreling of The University of Wisconsin-Madison School of Pharmacy found that potentially misleading claims are prevalent throughout consumer-targeted prescription and non-prescription ...

Scientists create extremely potent and improved derivatives of successful anticancer drug

2013-09-17
LA JOLLA, CA—September 16, 2013—Scientists at The Scripps Research Institute (TSRI) have found a way to make dramatic improvements to the cancer cell-killing power of vinblastine, one of the most successful chemotherapy drugs of the past few decades. The team's modified versions of vinblastine showed 10 to 200 times greater potency than the clinical drug. Even more significantly, these new compounds overcome the drug resistance that emerges upon treatment relapse, which renders continued or subsequent vinblastine treatment ineffective in some patients. The TSRI researchers ...

Invention jet prints nanostructures with self-assembling material

2013-09-17
A multi-institutional team of engineers has developed a new approach to the fabrication of nanostructures for the semiconductor and magnetic storage industries. This approach combines top-down advanced ink-jet printing technology with a bottom-up approach that involves self-assembling block copolymers, a type of material that can spontaneously form ultrafine structures. The team, consisting of nine researchers from the University of Illinois at Urbana-Champaign, the University of Chicago and Hanyang University in Korea, was able to increase the resolution of their intricate ...

Quitting Facebook -- what's behind the new trend to leave social networks?

2013-09-17
New Rochelle, NY, September 16, 2013—If you are ready to commit "virtual identity suicide," delete your Facebook account, and say good-bye to social networking sites, you are not alone. A social networking counter movement is emerging, and Facebook quitters, who remove their accounts, differ from Facebook users in several key ways, as described in an article in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Cyberpsychology, Behavior, and Social Networking website. Stefan ...

UC Davis study applies timely cost-effectiveness analysis to state breast cancer screening program

2013-09-17
(SACRAMENTO, Calif.) — When public health budgets are constrained, mammography screening should begin later and occur less frequently, a cost-effectiveness analysis for California's Every Woman Counts (EWC) program concludes. As outlined in a paper published in Value in Health, the analysis focused on several policy questions, including the effect on EWC program costs and outcomes of starting screening at age 50 years instead of 40 and of screening every two years instead of every year. The study was conducted in response to recent government funding cutbacks. "This ...

Depletion of 'traitor' immune cells slows cancer growth in mice

2013-09-17
When a person has cancer, some of the cells in his or her body have changed and are growing uncontrollably. Most cancer drugs try to treat the disease by killing those fast-growing cells, but another approach called immunotherapy tries to stimulate a person's own immune system to attack the cancer itself. Now, scientists at the University of Washington have developed a strategy to slow tumor growth and prolong survival in mice with cancer by targeting and destroying a type of cell that dampens the body's immune response to cancer. The researchers published their findings ...

Yale researchers see decline in hospitalizations for serious heart infection

2013-09-17
Hospitalizations for endocarditis, a deadly heart infection that disproportionately affects older heart patients, have declined in recent years despite recommendations for limited use of antibiotics to prevent the illness. These findings were recently published by Yale School of Medicine researchers in the Journal of the American College of Cardiology. Endocarditis is the most serious infection of the cardiovascular system, and the risk increases with surgical procedures. Past studies showed a marked increase in endocarditis hospitalization rates during the 1990s. As ...

'Vicious cycle' shields, spreads cancer cells

2013-09-17
HOUSTON – (Sept. 16, 2013) – A "vicious cycle" produces mucus that protects uterine and pancreatic cancer cells and promotes their proliferation, according to researchers at Rice University. The researchers offer hope for a therapeutic solution. They found that protein receptors on the surface of cancer cells go into overdrive to stimulate the production of MUC1, a glycoprotein that forms mucin, aka mucus. It covers the exposed tips of the elongated epithelial cells that coat internal organs like lungs, stomachs and intestines to protect them from infection. But when ...

Rare gene variant linked to macular degeneration

2013-09-17
AUDIO: Researchers from around the world, led by scientists at the Genome Institute at Washington University School of Medicine and the University of Michigan School of Public Gealth, have identified a... Click here for more information. An international team of researchers, led by scientists at The Genome Institute at Washington University School of Medicine in St. Louis and the University of Michigan School of Public Health in Ann Arbor, has identified a gene mutation ...

Immune system marker tied to improved bone marrow transplant outcomes

2013-09-17
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology. The research builds on an earlier St. Jude discovery that specialized immune cells called natural killer (NK) cells dispatched cancer cells more efficiently when the NK cells carried a particular version of a KIR protein on ...

Arginine therapy shows promise for sickle cell pain

2013-09-17
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain. Sickle cell disease is an inherited condition in which the body makes red blood cells containing abnormal hemoglobin, the protein that carries oxygen from the lungs to other cells in the body. This abnormal hemoglobin (hemoglobin S) causes ...

Rensselaer researchers create accurate computer model of RNA tetraloop

2013-09-17
Troy, N.Y. – A computational model developed by researchers at Rensselaer Polytechnic Institute is the first to accurately simulate the complex twists of a short sequence of RNA as it folds into a critical hairpin structure known as a "tetraloop." The research, published today in Proceedings of the National Academy of Sciences, is a glimpse into RNA, found in all life on Earth, and could advance a variety of research areas, including the search for new antibiotics and cures for protein-related diseases. Existing computational models, based on DNA rather than RNA, do not ...

On the road to fault-tolerant quantum computing

2013-09-17
Reliable quantum computing would make it possible to solve certain types of extremely complex technological problems millions of times faster than today's most powerful supercomputers. Other types of problems that quantum computing could tackle would not even be feasible with today's fastest machines. The key word is "reliable." If the enormous potential of quantum computing is to be fully realized, scientists must learn to create "fault-tolerant" quantum computers. A small but important step toward this goal has been achieved by an international collaboration of researchers ...

MicroRNA molecule found to be a potent tumor-suppressor in lung cancer

2013-09-17
COLUMBUS, Ohio – New research shows that microRNA-486 is a potent tumor-suppressor molecule in lung cancer, and that the it helps regulate the proliferation and migration of lung-cancer cells, and the induction of programmed cell death, or apoptosis, in those cells. The preclinical study was led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). It found that microRNA-486 (miR-486) directly targets the insulin growth-factor pathway, which is important for ...
Previous
Site 4020 from 8514
Next
[1] ... [4012] [4013] [4014] [4015] [4016] [4017] [4018] [4019] 4020 [4021] [4022] [4023] [4024] [4025] [4026] [4027] [4028] ... [8514]

Press-News.org - Free Press Release Distribution service.